1 |
Acthar low dose (40 u) |
- |
- |
- |
- |
049 [1] 49 💬 |
2 |
Administration of a low dose of desipramine |
Desipramine |
[2] D00812 D00812, D07791 D07791 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
156 [1] 156 💬 |
3 |
Ambrisentan - low dose |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
4 |
Bi 655064 low dose |
- |
- |
- |
- |
046 [1] 46 💬 |
5 |
Biil 284 bs low dose |
- |
- |
- |
- |
046 [1] 46 💬 |
6 |
Biil 284 bs, low dose |
- |
- |
- |
- |
299 [1] 299 💬 |
7 |
Biil 284 bs, low dose, adult patients |
- |
- |
- |
- |
299 [1] 299 💬 |
8 |
Biil 284 bs, low dose, pediatric patients |
- |
- |
- |
- |
299 [1] 299 💬 |
9 |
Birb 796 bs, low dose |
- |
- |
- |
- |
046 [1] 46 💬 |
10 |
Bli-1300 low dose |
- |
- |
- |
- |
096 [1] 96 💬 |
11 |
Brazikumab low dose |
Brazikumab |
[1] D10912 D10912 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 [1] 96 💬 |
12 |
Clobazam low dose |
Clobazam |
[1] D01253 D01253 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
144 [1] 144 💬 |
13 |
Cvn424 low dose |
- |
- |
- |
- |
006 [1] 6 💬 |
14 |
Cvt-301 low dose |
- |
- |
- |
- |
006 [1] 6 💬 |
15 |
Cyclosporin, low dose steroid |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
16 |
Elamipretide (low dose) |
Elamipretide |
[1] D10925 D10925 💬 |
- |
- |
021 [1] 21 💬 |
17 |
Eur-1008 (apt-1008) low dose |
- |
- |
- |
- |
298 [1] 298 💬 |
18 |
Fentanyl (low dose) |
Fentanyl |
[2] D00320 D00320, D01399 D01399 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
215 [1] 215 💬 |
19 |
Fentanyl (low dose) + dexmedetomidine |
Dexmedetomidine |
[4] D00320 D00320, D00514 D00514, D01205 D01205, D01399 D01399 💬 |
ADRA2A [4] ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 |
Estrogen signaling pathway [4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
20 |
Hmpl-004 low dose |
- |
- |
- |
- |
097 [1] 97 💬 |
21 |
Igpro20 (low dose) |
- |
- |
- |
- |
014 [1] 14 💬 |
22 |
Iloprost low dose |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
23 |
Kps-0373, low dose |
- |
- |
- |
- |
018 [1] 18 💬 |
24 |
Kw-6356 low dose |
- |
- |
- |
- |
006 [1] 6 💬 |
25 |
Liris low dose and liris high dose |
- |
- |
- |
- |
226 [1] 226 💬 |
26 |
Low dose |
- |
- |
- |
- |
097 [1] 97 💬 |
27 |
Low dose affitope® pd03a + adjuvant |
- |
- |
- |
- |
006 [1] 6 💬 |
28 |
Low dose arm receiving neutral oil and 400 iu/g of vitamin d every second day |
Vitamin D |
- |
- |
- |
013 [1] 13 💬 |
29 |
Low dose aspirin (162 mg/day) |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
30 |
Low dose bibf 1120 twice daily |
- |
- |
- |
- |
085 [1] 85 💬 |
31 |
Low dose bibf1120 once daily |
- |
- |
- |
- |
085 [1] 85 💬 |
32 |
Low dose budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
33 |
Low dose budesonide tablet |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [1] 98 💬 |
34 |
Low dose cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
35 |
Low dose mesenchymal stem cells (mscs) |
- |
- |
- |
- |
049 [1] 49 💬 |
36 |
Low dose naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
096 [2] 96, 97 💬 |
37 |
Low dose of biil 284 bs tablets |
- |
- |
- |
- |
046 [1] 46 💬 |
38 |
Low dose ortd-1 |
- |
- |
- |
- |
046 [1] 46 💬 |
39 |
Low dose prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
40 |
Low dose tso |
- |
- |
- |
- |
096 [1] 96 💬 |
41 |
Low dose vehicle control |
- |
- |
- |
- |
046 [1] 46 💬 |
42 |
Low dose-vis649 |
- |
- |
- |
- |
066 [1] 66 💬 |
43 |
Lx3305 low dose |
- |
- |
- |
- |
046 [1] 46 💬 |
44 |
Medi7183 low dose |
- |
- |
- |
- |
097 [1] 97 💬 |
45 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
46 |
Mt-1303 low dose |
- |
- |
- |
- |
049 [1] 49 💬 |
47 |
Mt-7117 low dose |
- |
- |
- |
- |
254 [1] 254 💬 |
48 |
Multistem low dose |
MultiStem |
- |
- |
- |
097 [1] 97 💬 |
49 |
Mycophenolate mofetil, low dose steroid |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
222 [1] 222 💬 |
50 |
Other: low dose (1 mcg) acth stimulation test |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
193 [1] 193 💬 |
51 |
Pf-06649751 low dose (1 mg qd) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
52 |
Prednisone, low dose rituximab |
Prednisone |
[2] D00473 D00473, D02994 D02994 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
061 [1] 61 💬 |
53 |
Pxt3003 low dose |
- |
- |
- |
- |
010 [1] 10 💬 |
54 |
Ravicti low dose |
- |
- |
- |
- |
299 [1] 299 💬 |
55 |
Sen0014196 (low dose) |
- |
- |
- |
- |
008 [1] 8 💬 |
56 |
Tas5315 low dose |
- |
- |
- |
- |
046 [1] 46 💬 |
57 |
Tiotropium bromide-low dose-2.5mcg |
Tiotropium |
- |
- |
- |
299 [1] 299 💬 |
58 |
Ursodeoxycholic acid+low dose glucocorticoid(prednisone) |
Prednisone |
[2] D00473 D00473, D00734 D00734 💬 |
NR1H4 [2] NR1H4, NR3C1 💬 |
Bile secretion [2] Bile secretion, Neuroactive ligand-receptor interaction |
093 [1] 93 💬 |
59 |
Yra-1909 low dose |
- |
- |
- |
- |
046 [1] 46 💬 |